Cite
HARVARD Citation
de Castro, G. et al. (2018). Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: Consensus opinion from a panel of experts. Critical reviews in oncology/hematology. pp. 30-34. [Online].